Aflibercept for age-related macular degeneration: 4-year outcomes of a ‘treat-and-extend’ regimen with exit-strategy | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Clinical science

Aflibercept for age-related macular degeneration: 4-year outcomes of a ‘treat-and-extend’ regimen with exit-strategy

Online download statistics by month:

Online download statistics by month: October 2020 to September 2022

	Abstract	Full	Pdf
Oct 2020	401	400	95
Nov 2020	1945	1933	1545
Dec 2020	781	767	418
Jan 2021	154	152	38
Feb 2021	122	119	33
Mar 2021	130	126	51
Apr 2021	126	124	20
May 2021	195	193	33
Jun 2021	112	111	16
Jul 2021	113	109	15
Aug 2021	131	128	26
Sep 2021	113	109	23
Oct 2021	118	115	44
Nov 2021	109	103	31
Dec 2021	122	121	26
Jan 2022	525	524	49
Feb 2022	292	297	54
Mar 2022	113	110	43
Apr 2022	149	138	54
May 2022	114	110	61
Jun 2022	104	101	44
Jul 2022	84	79	31
Aug 2022	83	74	18
Sep 2022	93	87	43
Total	6229	6130	2811